HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jawahar L Mehta Selected Research

Protein Isoforms (Isoforms)

1/2019Vitamin E and its anticancer effects.
1/2012Functional characterization and expression analysis of novel alternative splicing isoforms of Olr1 gene during mouse embryogenesis.
7/2005In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jawahar L Mehta Research Topics

Disease

84Atherosclerosis
07/2022 - 03/2001
25Inflammation (Inflammations)
06/2022 - 01/2002
25Cardiovascular Diseases (Cardiovascular Disease)
11/2020 - 09/2002
23Hypertension (High Blood Pressure)
01/2021 - 06/2003
13Myocardial Infarction
11/2018 - 11/2002
11Neoplasms (Cancer)
01/2022 - 01/2003
11Hypoxia (Hypoxemia)
11/2018 - 02/2002
10COVID-19
08/2022 - 01/2020
10Fibrosis (Cirrhosis)
01/2021 - 12/2004
10Coronary Artery Disease (Coronary Atherosclerosis)
04/2018 - 09/2002
10Myocardial Ischemia (Ischemic Heart Diseases)
06/2017 - 03/2003
10Dyslipidemias (Dyslipidemia)
02/2014 - 06/2003
9Infections
08/2022 - 09/2005
9Infarction (Infarctions)
11/2021 - 03/2003
9Atherosclerotic Plaque (Atheroma)
07/2019 - 08/2003
8Thrombosis (Thrombus)
02/2022 - 03/2005
8Heart Failure
01/2022 - 09/2004
8Ischemia
11/2021 - 03/2003
8Stroke (Strokes)
01/2019 - 02/2011
7Diabetes Mellitus
10/2017 - 10/2006
7Hypertrophy
10/2011 - 08/2006
5Acute Coronary Syndrome
01/2020 - 05/2007
5Necrosis
01/2016 - 03/2003
5Coronary Disease (Coronary Heart Disease)
06/2012 - 06/2003
4Type 2 Diabetes Mellitus (MODY)
01/2022 - 08/2006
4Ischemic Stroke
01/2019 - 06/2013
4Reperfusion Injury
05/2018 - 03/2003
4Multiple Myeloma
12/2017 - 11/2003
4Obesity
12/2014 - 08/2006
3Cardiomyopathies (Cardiomyopathy)
01/2022 - 03/2006
3Atrial Fibrillation
10/2019 - 05/2010
3Rupture
10/2013 - 08/2004
2Virus Diseases (Viral Diseases)
08/2022 - 01/2020
2Disease Progression
01/2022 - 09/2005
2Hypoglycemia (Reactive Hypoglycemia)
01/2022 - 01/2021
2Sepsis (Septicemia)
01/2022 - 01/2007
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2022 - 01/2022
2Cicatrix (Scar)
11/2021 - 05/2007
2Myocarditis (Carditis)
10/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

49oxidized low density lipoproteinIBA
08/2022 - 03/2001
14LectinsIBA
01/2022 - 03/2003
13CollagenIBA
11/2021 - 10/2006
13Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2017 - 08/2002
13Angiotensin IIIBA
05/2016 - 03/2001
12CholesterolIBA
08/2022 - 09/2002
12Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 03/2003
11CytokinesIBA
06/2022 - 01/2006
11Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2021 - 01/2005
10Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA
03/2015 - 10/2004
9Proteins (Proteins, Gene)FDA Link
04/2021 - 01/2006
9InflammasomesIBA
04/2021 - 09/2014
9Oxidized LDL ReceptorsIBA
08/2016 - 03/2003
8LipidsIBA
08/2022 - 09/2004
8LDL CholesterolIBA
08/2022 - 09/2002
8AntioxidantsIBA
07/2019 - 03/2001
8LDL Lipoproteins (beta Lipoproteins)IBA
11/2015 - 03/2001
7Scavenger Receptors (Scavenger Receptor)IBA
07/2019 - 07/2005
7Oxidants (Oxidizing Agents)IBA
01/2019 - 02/2002
6Biomarkers (Surrogate Marker)IBA
11/2020 - 11/2004
5Fibronectins (Fibronectin)IBA
11/2021 - 12/2012
5EnzymesIBA
01/2020 - 08/2006
5Matrix Metalloproteinases (MMPs)IBA
09/2007 - 05/2003
4Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2020 - 10/2006
4Mitochondrial DNA (mtDNA)IBA
09/2014 - 01/2013
4Rosuvastatin Calcium (Crestor)FDA Link
12/2009 - 10/2004
4LDL Receptors (LDL Receptor)IBA
10/2009 - 08/2003
4Pioglitazone (Actos)FDA Link
09/2009 - 12/2004
4PPAR gammaIBA
03/2005 - 01/2002
4LigandsIBA
03/2005 - 01/2002
3Triglycerides (Triacylglycerol)IBA
08/2022 - 09/2002
3COVID-19 VaccinesIBA
05/2022 - 10/2021
3VaccinesIBA
02/2022 - 11/2017
3Metalloproteases (Metalloproteinases)IBA
01/2019 - 07/2003
3Protein Isoforms (Isoforms)IBA
01/2019 - 07/2005
3Small Interfering RNA (siRNA)IBA
11/2018 - 01/2013
3Glucagon-Like Peptide 1 (GLP 1)IBA
09/2016 - 10/2013
3NADPH Oxidases (NAD(P)H oxidase)IBA
01/2016 - 03/2012
3Dipeptidyl-Peptidase IV InhibitorsIBA
01/2016 - 01/2014
3AngiotensinsIBA
11/2013 - 02/2008
3Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
10/2013 - 02/2006
33-nitrotyrosineIBA
11/2010 - 10/2004
3Immunoglobulin G (IgG)IBA
07/2010 - 11/2002
3CurcuminIBA
04/2010 - 03/2009
3Transforming Growth Factor beta1 (TGF beta 1)IBA
10/2009 - 05/2003
3AutoantigensIBA
10/2007 - 11/2003
3Collagen Type I (Type I Collagen)IBA
09/2007 - 11/2004
3C-Reactive ProteinIBA
04/2007 - 09/2005
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
03/2005 - 01/2002
2HDL CholesterolIBA
08/2022 - 09/2002
2Pharmaceutical PreparationsIBA
01/2022 - 01/2005
2Prasugrel HydrochlorideFDA Link
09/2021 - 10/2019
2Caspase 1 (ICE Protease)IBA
04/2021 - 05/2018
2Blood Glucose (Blood Sugar)IBA
01/2021 - 09/2016
2Angiotensin-Converting Enzyme 2IBA
01/2021 - 01/2020
2LiraglutideFDA Link
01/2021 - 01/2016

Therapy/Procedure

29Therapeutics
08/2022 - 03/2001
6Ligation
11/2021 - 03/2003
5Percutaneous Coronary Intervention
10/2019 - 07/2006
3Diet Therapy (Therapy, Diet)
06/2013 - 07/2006
3Stents
09/2007 - 07/2006